Education
About Us
Working with TipRanks
Follow Us
Allergy Therapeutics PLC (GB:AGY)
LSE:AGY
AGY Stock Chart & Stats
7.75p
-0.04p(-0.55%)
At close: 4:00 PM EST
7.75p
-0.04p(-0.55%)
Day’s Range― - ―
52-Week Range4.50p - 9.00p
Previous CloseN/A
Volume22.64K
Average Volume (3M)213.96K
Market Cap
£369.40M
Enterprise Value332.66M
Total Cash (Recent Filing)£21.68M
Total Debt (Recent Filing)£44.52M
Price to Earnings (P/E)―
Beta0.65
Next Earnings
Feb 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding4,766,440,000
10 Day Avg. Volume223,352
30 Day Avg. Volume213,956
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)47.44
Price to Sales (P/S)3.19
P/FCF Ratio-4.95
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£8.50Price Target Upside9.68% Upside
Rating ConsensusHold
Number of Analyst Covering0
Allergy Therapeutics News
AGY FAQ
What was Allergy Therapeutics PLC’s price range in the past 12 months?
Allergy Therapeutics PLC lowest share price was 4.50p and its highest was 9.00p in the past 12 months.
What is Allergy Therapeutics PLC’s market cap?
Allergy Therapeutics PLC’s market cap is £369.40M.
When is Allergy Therapeutics PLC’s upcoming earnings report date?
Allergy Therapeutics PLC’s upcoming earnings report date is Feb 26, 2026 which is in 129 days.
How were Allergy Therapeutics PLC’s earnings last quarter?
Currently, no data Available
Is Allergy Therapeutics PLC overvalued?
According to Wall Street analysts Allergy Therapeutics PLC’s price is currently Undervalued.
Does Allergy Therapeutics PLC pay dividends?
Allergy Therapeutics PLC does not currently pay dividends.
What is Allergy Therapeutics PLC’s EPS estimate?
Allergy Therapeutics PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Allergy Therapeutics PLC have?
Allergy Therapeutics PLC has 4,766,440,000 shares outstanding.
What happened to Allergy Therapeutics PLC’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Allergy Therapeutics PLC?
Currently, no hedge funds are holding shares in GB:AGY
Allergy Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
£8.50 (9.68% Upside)
£8.50 (9.68% Upside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
63.15%
12-Months-Change
Fundamentals
Return on Equity
-369.20%
Trailing 12-Months
Asset Growth
5.64%
Trailing 12-Months
Company Description
Allergy Therapeutics PLC
Allergy Therapeutics (AGY) is a leading biotechnology company specializing in the development and commercialization of allergy immunotherapy solutions. Operating within the healthcare and pharmaceuticals sector, the company focuses on transforming the treatment of allergies through innovative vaccines and treatments. Its core products are designed to provide long-term relief to patients suffering from various allergic conditions, significantly improving their quality of life.
Technical Analysis
Options Prices
Currently, No data available
---